The voice of people

with MS in Europe

EUReMS

European Register for Multiple Sclerosis

EUReMS logoThe European Register for Multiple Sclerosis (EUReMS) is a cross-border MS data collection system which EMSP and the project stakeholders developed between 2011 and 2014, enabling better data for better outcomes.

 

Find updates on EUReMS here.

 

Find a project report here

 

Background information

 

The project is supported by a sustainable European Network of over ten national MS data registers.

 

The test phase studies will address: Epidemiology of MS, Disease Modifying Drugs Access and Long term Efficacy, Quality of life in MS and Health Economics. These studies will be run between April 2013 and June 2014.

 

EMSP is pleased to acknowledge and thank its supporters and sponsors for the EUReMS project. Especially, we would like to mention the support of ECTRIMS which hosted the EUReMS project meeting during its 28th Annual Congress and was represented there by Prof. Maria Trojano, newly appointed President of ECTRIMS. Professor Maria Trojano renewed her support to the EUReMS project on behalf of ECTRIMS and expressed her willingness to collaborate further on this important initiative.

 

 

The EUReMS project has received co-funding from the European Union, in the framework of the Second Health Programme 2008-2013.

About the EUReMS project

MS-ID project (2007-2009) demonstrated the feasibility of an European Register for Multiple Sclerosis. Therefore EMSP pursued its efforts in order to prepare the upcoming project so called “European Register for Multiple Sclerosis (EUReMS) – A tool to assess, compare and enhance the status of people with MS throughout the EU”.

 

Full title: European Register for Multiple Sclerosis – A tool to assess, compare and enhance the status of People with MS throughout the EU

 

Co-Funded by: EC Public Health Programme, Call 2010 – Priority area: 3.3..2 Promote health – Promote healthier ways of life and reduce major diseases and rare diseases – Subaction: Neurodegenerative diseases-launch first phase of multiple sclerosis

 

Duration: 36 months

 

Start date: 1 July 2011

 

Total budget: EUR 1.646.503,00

 

EC Contribution: EUR 987.198,00

 

The EUReMS has received co-funding from the European Union, in the framework of the Health Programme: